| 22 | 1/1 | 返回列表 |
| 查看: 775 | 回復: 21 | |||
| 【有獎交流】積極回復本帖子,參與交流,就有機會分得作者 烏托小邦 的 29 個金幣 ,回帖就立即獲得 1 個金幣,每人有 1 次機會 | |||
[交流]
美國內(nèi)布拉斯加大學醫(yī)學中心招聘發(fā)育生物學和心臟再生相關研究博士后
|
|||
|
Dr. Wei Shi's laboratory at the University of Nebraska Medical Center (UNMC) is seeking a highly motivated and talented Postdoctoral Research Associate. The research of the Shi Lab focuses on the epigenetic mechanisms that regulate embryonic heart development, with a particular emphasis on chromatin remodeling complexes (Robbe and Shi, et al., Genes & Development, 2022; Shi, et al., Circulation Research, 2023; Shi et al., Development, 2024; Shi and Sheng, et al., Developmental Cell, 2021). The long-term goal of the Shi Lab is to leverage these developmental insights to innovate regenerative approaches for treating heart diseases in adults. The successful candidate will lead a research program to understand how chromatin remodeling complexes control cardiomyocyte maturation and cellular interactions during neonatal heart development. This position offers the unique opportunity to collaborate with the Departments of Internal Medicine, Physiology, Biochemistry, and the Mary and Holland Dick Regenerative Medicine Program at UNMC, providing extensive training and networking opportunities in cardiovascular disease, developmental biology, and biomaterials-based regenerative medicine. Recruited candidates will benefit from a competitive salary and benefits package, along with comprehensive training in grant writing, application processes, and career development. Essential Job Duties and Responsibilities: • Design and conduct experiments, maintaining detailed experimental records and documentation. • Analyze experimental results in collaboration with the Principal Investigator. • Develop, adapt, and implement new research techniques and protocols as needed. • Interpret, summarize, and compile data for publication and presentation. • Perform routine and complex laboratory procedures throughout the training period. Qualifications: • Ph.D. or M.D./Ph.D. in Developmental Biology, Cell Biology, Biochemistry, Pathology, or a related discipline. (Candidates expected to complete their degree within the next six months are also encouraged to apply.) • Strong publication record. • Experience with rodent models, cardiovascular cell biology, or bioinformatics is highly desirable. • Candidates with relevant experience holding a B.S. or Master’s degree are encouraged to apply for the Research Technologist positions in the lab or UNMC graduate students programs. Application Process: Interested candidates should directly send a CV and the contact information for two references to Wei Shi, Ph.D., Email: weshi@unmc.edu |
» 搶金幣啦!回帖就可以得到:
+2/48
+2/38
+1/34
+1/26
+1/25
+1/24
+1/8
+1/7
+1/7
+1/6
+1/6
+1/5
+1/5
+1/4
+1/4
+1/3
+1/3
+1/3
+1/2
+1/2





| 22 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 289求調(diào)劑 +3 | 步川酷紫123 2026-03-11 | 3/150 |
|
|---|---|---|---|---|
|
[考研] 考研材料與化工,求調(diào)劑 +7 | 戲精丹丹丹 2026-03-09 | 7/350 |
|
|
[考研] 化工0817調(diào)劑 +8 | 燦若星晨 2026-03-10 | 8/400 |
|
|
[考研] 收調(diào)劑 +7 | 調(diào)劑的考研學生 2026-03-10 | 7/350 |
|
|
[考研] 材料與化工求調(diào)劑 +11 | 與冬清寧 2026-03-07 | 14/700 |
|
|
[考研] 材料與化工,291,求調(diào)劑 +12 | 咕嚕咕嚕123123 2026-03-05 | 13/650 |
|
|
[考研]
|
likeihood 2026-03-06 | 16/800 |
|
|
[考研] 310 070300化學求調(diào)劑 +4 | 撲風鈴的貓 2026-03-08 | 5/250 |
|
|
[考研] 0703求調(diào)劑 +10 | c297914 2026-03-06 | 11/550 |
|
|
[考研] 求調(diào)劑,數(shù)一英一274分 +4 | 小菲會努力 2026-03-08 | 4/200 |
|
|
[考研] 297求調(diào)劑 +3 | 胡達靈 2026-03-05 | 5/250 |
|
|
[考研] 考研求調(diào)劑,工科,總分304 +4 | 矮子不想長高了 2026-03-08 | 7/350 |
|
|
[考研] 269求調(diào)劑 +3 | 朔朔話 2026-03-08 | 4/200 |
|
|
[考研] 286求調(diào)劑 +12 | Faune 2026-03-06 | 14/700 |
|
|
[考研] 一志愿中國石油大學(華東) 本科齊魯工業(yè)大學 求調(diào)劑 +3 | snw石 2026-03-07 | 3/150 |
|
|
[考研] 308求調(diào)劑 +7 | 倘若起風了呢 2026-03-05 | 9/450 |
|
|
[考研] 化工282求調(diào)劑一志愿211 +5 | NA0912 2026-03-05 | 6/300 |
|
|
[考研] 材料調(diào)劑 +5 | ws 上岸鴨 2026-03-05 | 5/250 |
|
|
[考研] 材料調(diào)劑 +4 | L9370 2026-03-05 | 4/200 |
|
|
[考研] 316求調(diào)劑 +3 | 林小星發(fā)大財 2026-03-04 | 3/150 |
|